These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2241185

  • 1. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
    Fukuoka M, Miyazaki T, Yoshida Y, Hattori M, Niitani H, Nakamura T, Hirota Y, Ohta K, Tanaka M, Suzuoki Y.
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2213-9. PubMed ID: 2241185
    [Abstract] [Full Text] [Related]

  • 2. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
    Tatsumi N, Yamada K, Ohshima T, Nakamura T, Ohno R, Masaoka T, Kimura I, Kimura K.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
    [Abstract] [Full Text] [Related]

  • 3. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
    Nishikawa M, Morita K, Komada F, Uemura Y, Kageyama S, Minami N, Deguchi K, Shirakawa S.
    Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
    [Abstract] [Full Text] [Related]

  • 4. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
    Nagahata T, Shibasaki C, Ishii T, Uchida T, Arakawa M, Kusama K, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
    Schleyer E, Braess J, Ramsauer B, Unterhalt M, Kaufmann C, Wilde S, Schüssler M, Hiddemann W.
    Leukemia; 1995 Jun; 9(6):1085-90. PubMed ID: 7596174
    [Abstract] [Full Text] [Related]

  • 6. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
    Suto T, Yoshida Y, Sakata Y, Ono T, Yoshida T, Yamada N, Chida N, Oohira H.
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
    Ueda T, Kamiya K, Urasaki Y, Wataya S, Kawai Y, Tsutani H, Sugiyama M, Nakamura T.
    Cancer Res; 1994 Jan 01; 54(1):109-13. PubMed ID: 8261429
    [Abstract] [Full Text] [Related]

  • 8. Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
    Braess J, Freund M, Hanauske A, Heil G, Kaufmann C, Kern W, Schüssler M, Hiddemann W, Schleyer E.
    Leukemia; 1998 Oct 01; 12(10):1618-26. PubMed ID: 9766508
    [Abstract] [Full Text] [Related]

  • 9. [A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
    Ueda Y, Mori S, Ito T, Maesako Y, Konishi H, Yagiri Y.
    Rinsho Ketsueki; 1998 May 01; 39(5):348-54. PubMed ID: 9637884
    [Abstract] [Full Text] [Related]

  • 10. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M, Jeha S, O'Brien S, Estey E, Vitek L, Zurlo MG, Rios MB, Keating M, Kantarjian H.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [Abstract] [Full Text] [Related]

  • 11. [Clinical efficacy of YNK 01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) in patients with polycythemia vera].
    Naito K, Kitaori K, Morishima Y.
    Gan To Kagaku Ryoho; 1993 May 01; 20(7):973-6. PubMed ID: 8489306
    [No Abstract] [Full Text] [Related]

  • 12. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T.
    Gan To Kagaku Ryoho; 1995 Feb 01; 22(2):259-71. PubMed ID: 7857102
    [Abstract] [Full Text] [Related]

  • 13. Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate.
    Ohno R, Tatsumi N, Hirano M, Imai K, Mizoguchi H, Nakamura T, Kosaka M, Takatsuki K, Yamaya T, Toyama K.
    Oncology; 1991 Feb 01; 48(6):451-5. PubMed ID: 1749580
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of myelodysplastic syndromes (MDS) with oral administration of N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine (PLAC)].
    Ohno R, Kimura K.
    Gan To Kagaku Ryoho; 1988 Apr 01; 15(4 Pt 2-2):1205-8. PubMed ID: 3382195
    [Abstract] [Full Text] [Related]

  • 15. [Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
    Tsutsumi H, Kumakawa T, Hirai M, Kikukawa M, Arie Y, Mori M, Kodo H, Nakamura N, Murai Y, Mizutani R.
    Nihon Ronen Igakkai Zasshi; 1995 Mar 01; 32(3):190-4. PubMed ID: 7596061
    [Abstract] [Full Text] [Related]

  • 16. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
    Yano K, Matsui H, Fujisawa S.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25(3):427-30. PubMed ID: 9492840
    [No Abstract] [Full Text] [Related]

  • 17. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
    Inaba T, Shimazaki C, Tatsumi T, Yamagata N, Hirata T, Goto H, Fujita N, Nakagawa M, Fujita N, Miyazaki S.
    Gan To Kagaku Ryoho; 1994 Mar 01; 21(4):535-8. PubMed ID: 8129396
    [Abstract] [Full Text] [Related]

  • 18. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ, Burris H, Schellens JH, Eckardt JR, Planting AS, van der Burg ME, Rodriguez GI, Loos WJ, van Beurden V, Hudson I, Fields S, Von Hoff DD, Verweij J.
    Clin Cancer Res; 1998 May 01; 4(5):1153-8. PubMed ID: 9607572
    [Abstract] [Full Text] [Related]

  • 19. [Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
    Im T, Ota K, Ohira H, Yasui Y, Nakao Y, Furukawa Y, Inoue K, Yamane T, Hiyoshi M, Kishida T.
    Gan To Kagaku Ryoho; 1991 Jan 01; 18(1):139-42. PubMed ID: 1987896
    [No Abstract] [Full Text] [Related]

  • 20. [Phase I clinical study of TT-62. Research group of TT-62].
    Taguchi T, Furue H, Niitani H, Ohta K, Tsukagoshi S, Wakui A, Hasegawa K, Nakao I, Ohashi Y, Tominaga T.
    Gan To Kagaku Ryoho; 1993 Feb 01; 20(2):241-6. PubMed ID: 8434962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.